Explore Mazdutide dosage trends, reconstitution volumes, and vial size patterns from anonymized WPA peptide calculator sessions.
Mazdutide (IBI362 / LY3305677) is a GLP-1 and glucagon receptor dual agonist based on the oxyntomodulin backbone, developed by Innovent and Eli Lilly and studied in the GLORY program for obesity and type 2 diabetes. Its glucagon arm adds an energy-expenditure component on top of GLP-1-driven appetite suppression. This data shows the dose amounts, vial sizes, and bacteriostatic water volumes researchers most commonly select when reconstituting Mazdutide.
4 Mazdutide reconstitution calculations have been logged by the WPA community. The most common dose entered is 250mcg (2 calculations). The median dose across all sessions is 4mg. The most common bacteriostatic water volume is 2mL. The most popular vial size is 12mg (4 sessions). The most common dosing frequency is once weekly (2 logged protocols), followed by 2x/week (1).
World Peptide Association aggregates anonymized peptide calculator data to show real-world dosing trends, reconstitution volumes, and vial size preferences across the research peptide community.
All figures shown are aggregated from anonymized calculator inputs and are provided strictly for independent laboratory research and educational purposes. They are community usage statistics — not dosing recommendations, and not medical advice.